IQVIA Holdings Inc.

IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Headquartered in Durham, North Carolina, the company's mission is to accelerate innovation for a healthier world, aiming to improve patient outcomes through a unique combination of data, technology, and healthcare expertise.

IQVIA offers a comprehensive portfolio of products and services, including clinical trial solutions, real-world data (RWD) and real-world evidence (RWE) solutions, and commercial solutions. Its technology offerings encompass platforms like Orchestrated Customer Engagement (OCE), Data-as-a-Service (DaaS), Integrated Data Platform (IDP), and Master Data Management (MDM), alongside advanced AI and agentic technologies. The company serves a diverse range of market segments within the business-to-business (B2B) sector of the life sciences industry, including pharmaceutical manufacturers, emerging biopharma, MedTech, generics manufacturers, consumer health, and government agencies.

Led by CEO Ari Bousbib, IQVIA positions itself as "The Human Data Science Company," leveraging its extensive data assets, advanced analytics, and deep industry knowledge. The company holds a significant market share in global health analytics and the contract research organization (CRO) market. Recent notable developments include the unveiling of IQVIA.ai, a unified agentic AI platform powered by NVIDIA in March 2026, and a strategic collaboration with AWS in January 2026. IQVIA was also named to the Fortune® World's Most Admired Companies™ List, ranking No. 1 in its sector for the fifth consecutive year in January 2026.